A study showed that galectin-10 concentrations in nasal secretions from patients with chronic rhinosinusitis with nasal polyps were a noninvasive biomarker that predicted a better response to glucocorticosteroids [87]. The gene discussed is CLC; the disease is Nasal polyposis.